Cargando…

Roles of Glutamate Receptors in Parkinson’s Disease

Parkinson’s disease is a progressive neurodegenerative disorder resulting from the degeneration of pigmented dopaminergic neurons in the substantia nigra pars compacta. It induces a series of functional modifications in the circuitry of the basal ganglia nuclei and leads to severe motor disturbances...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhu, Zhang, Shiqing, Fu, Pengfei, Zhang, Zhang, Lin, Kaili, Ko, Joshua Ka-Shun, Yung, Ken Kin-Lam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769661/ https://www.ncbi.nlm.nih.gov/pubmed/31500132 http://dx.doi.org/10.3390/ijms20184391

Ejemplares similares

MUC1: Structure, Function, and Clinic Application in Epithelial Cancers
por: Chen, Wenqing, et al.
Publicado: (2021)

Therapeutic Intervention in Cancer by Isoliquiritigenin from Licorice: A Natural Antioxidant and Redox Regulator
por: Zhang, Zhu, et al.
Publicado: (2022)

Oleanolic Acid Alleviates Cerebral Ischemia/Reperfusion Injury via Regulation of the GSK-3β/HO-1 Signaling Pathway
por: Lin, Kaili, et al.
Publicado: (2021)

Parkinson's Disease: Extracellular Nanomatrix‐Induced Self‐Organization of Neural Stem Cells into Miniature Substantia Nigra‐Like Structures with Therapeutic Effects on Parkinsonian Rats (Adv. Sci. 24/2019)
por: Zhang, Shiqing, et al.
Publicado: (2019)

20(S)-protopanaxadiol and oleanolic acid ameliorate cognitive deficits in APP/PS1 transgenic mice by enhancing hippocampal neurogenesis
por: Lin, Kaili, et al.
Publicado: (2021)

Aberrant Transferrin and Ferritin Upregulation Elicits Iron Accumulation and Oxidative Inflammaging Causing Ferroptosis and Undermines Estradiol Biosynthesis in Aging Rat Ovaries by Upregulating NF-Κb-Activated Inducible Nitric Oxide Synthase: First Demonstration of an Intricate Mechanism
por: Sze, Stephen Cho Wing, et al.
Publicado: (2022)

Protective Effect of An-Gong-Niu-Huang Wan Pre-treatment Against Experimental Cerebral Ischemia Injury via Regulating GSK-3β/HO-1 Pathway
por: Zhang, Shiqing, et al.
Publicado: (2021)

Metabotropic Glutamate Receptors for Parkinson's Disease Therapy
por: Gasparini, Fabrizio, et al.
Publicado: (2013)

A mini-review of the role of vesicular glutamate transporters in Parkinson’s disease
por: Zhao, Cheng, et al.
Publicado: (2023)

The human cathelicidin peptide LL-37 inhibits pancreatic cancer growth by suppressing autophagy and reprogramming of the tumor immune microenvironment
por: Zhang, Zhu, et al.
Publicado: (2022)

Isoalantolactone Induces Cell Cycle Arrest, Apoptosis and Autophagy in Colorectal Cancer Cells
por: Li, Junkui, et al.
Publicado: (2022)

20(S)-protopanaxadiol promotes the migration, proliferation, and differentiation of neural stem cells by targeting GSK-3β in the Wnt/GSK-3β/β-catenin pathway
por: Lin, Kaili, et al.
Publicado: (2020)

Glutamate Receptor Dysregulation and Platelet Glutamate Dynamics in Alzheimer’s and Parkinson’s Diseases: Insights into Current Medications
por: Gautam, Deepa, et al.
Publicado: (2023)

Glutamate Receptor Gene GRIN2A, Coffee, and Parkinson Disease
por: Hamza, Taye H., et al.
Publicado: (2014)

Nonlinear modulation of COVID‐19 transmission by climate conditions
por: Gao, Meng, et al.
Publicado: (2021)

Metabotropic glutamate receptor 5 inhibits α-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson’s disease
por: Zhang, Ya-Nan, et al.
Publicado: (2021)

Extracellular Nanomatrix‐Induced Self‐Organization of Neural Stem Cells into Miniature Substantia Nigra‐Like Structures with Therapeutic Effects on Parkinsonian Rats
por: Zhang, Shiqing, et al.
Publicado: (2019)

No association between Parkinson disease and autoantibodies against NMDA-type glutamate receptors
por: Hopfner, Franziska, et al.
Publicado: (2019)

Parkinson’s disease, epilepsy, and amyotrophic lateral sclerosis—emerging role of AMPA and kainate subtypes of ionotropic glutamate receptors
por: Vukolova, Marina N., et al.
Publicado: (2023)

Targeting metabotropic glutamate receptor 4 for cancer immunotherapy
por: Wan, Zhuoya, et al.
Publicado: (2021)

Molecular Mechanisms of Glutamate Toxicity in Parkinson’s Disease
por: Wang, Ji, et al.
Publicado: (2020)

The Role of Glutamate Receptors in Epilepsy
por: Chen, Tsang-Shan, et al.
Publicado: (2023)

Regulation of glutamate transporter trafficking by Nedd4-2 in a Parkinson's disease model
por: Zhang, Yunlong, et al.
Publicado: (2017)

Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease
por: Duty, Susan
Publicado: (2010)

The Role of Neuroglial Metabotropic Glutamate Receptors in Alzheimer’s Disease
por: Abd-Elrahman, Khaled S., et al.
Publicado: (2023)

Caffeine Interaction with Glutamate Receptor Gene GRIN2A: Parkinson's Disease in Swedish Population
por: Yamada-Fowler, Naomi, et al.
Publicado: (2014)

Dopamine Receptors and Parkinson's Disease
por: Hisahara, Shin, et al.
Publicado: (2011)

Endogenous Repair by the Activation of Cell Survival Signalling Cascades during the Early Stages of Rat Parkinsonism
por: Lui, Nga-Ping, et al.
Publicado: (2012)

Rapamycin upregulates glutamate transporter and IL-6 expression in astrocytes in a mouse model of Parkinson's disease
por: Zhang, Yunlong, et al.
Publicado: (2017)

Beyond Dopamine: GABA, Glutamate, and the Axial Symptoms of Parkinson Disease
por: O'Gorman Tuura, Ruth L., et al.
Publicado: (2018)

Does Prefrontal Glutamate Index Cognitive Changes in Parkinson’s Disease?
por: Buard, Isabelle, et al.
Publicado: (2022)

Glutamic Acid Transporters: Targets for Neuroprotective Therapies in Parkinson’s Disease
por: Li, Xiang, et al.
Publicado: (2021)

The Role of Metabotropic Glutamate Receptor Genes in Schizophrenia
por: Maj, Carlo, et al.
Publicado: (2016)

Role of Metabotropic Glutamate Receptors in Neurological Disorders
por: Crupi, Rosalia, et al.
Publicado: (2019)

The role of glutamate receptors in the regulation of the tumor microenvironment
por: Koda, Stephane, et al.
Publicado: (2023)

Glutamate Receptors in Neuroinflammatory Demyelinating Disease
por: Bolton, Christopher, et al.
Publicado: (2006)

Glutamate, Glutamate Receptors, and Downstream Signaling Pathways
por: Willard, Stacey S., et al.
Publicado: (2013)

Trafficking of the glutamate transporter is impaired in LRRK2-related Parkinson’s disease
por: Iovino, Ludovica, et al.
Publicado: (2022)

Expression and roles of glutamate (NMDA) receptors on T cell subsets
por: Orihara, Kanami, et al.
Publicado: (2010)

The Role of Metabotropic Glutamate Receptors in Social Behavior in Rodents
por: Zoicas, Iulia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q83gdcgg9iae6lgim5jmbq4pmq